Loading

Weekly Newsletter

Sunday, July 6, 2025

Features of the week

A Multi-Faceted Attempt to Attain Whole New Levels of Patient Engagement

Wilma™, a leading AI-powered practice management solution tailored for Applied Behavior Analysis (ABA) therapy practices, has officially announced the launch of its refreshed Patient Relationship Management capabilities. According to certain reports, this assortment of capabilities arrives on the scene bearing...

Value-Based Care Summit 2025: Shaping the Future of Healthcare Delivery

Boston, MA – September 18-19, 2025 – marcus evans is proud to announce the Value-Based Care Summit, an exclusive, invitation-only event bringing together senior executives from public and private health insurance plans, ACOs, integrated hospital systems, independent physician groups,...

Revolutionizing Clinical Research: Evolution Summit 2025 to Bring Together Industry Pioneers in Montreux, Switzerland

Montreux, Switzerland – Marcus Evans is proud to announce the Evolution Europe Summit 2025, an exclusive, invitation-only forum uniting Europe’s leading clinical research and development executives with innovative solution providers. The event will take place on October 2-3, 2025,...

Revolutionizing Clinical Trials: Evolution Summit 2025 Returns to San Diego

Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers, and solution providers. Set against the luxurious backdrop of the Park Hyatt Aviara Resort, Golf Club...

Featured Vendors

Featured Insights

The role of the CRO in enabling the shift from Hospital to Community 

CROs play a crucial role in facilitating the shift of care from hospital to the community and supporting increased commercial clinical trials activity across the UK. Experts, the government, and the health service have identified three shifts that will be...

How Digital Opinion Leaders Are Transforming Clinical Trial Awareness

The Bottleneck in Clinical Trial Enrollment Clinical trial enrollment delays remain one of the costliest, most persistent challenges in drug development, especially in rare diseases, oncology, and other specialty conditions. Traditional recruitment channels, which include outreach through clinical trial sites,...

The Changing CRO Environment: Responding to New Models of Service Delivery and Change

Contract Research Organizations (CROs) are undergoing major changes driven by a variety of factors. Pressures in the field include compressed timelines, demands for greater efficiency and cost competitiveness, advances in technology, and a heightened emphasis on relationships with research...

Why CROs Are Still Losing the Recruitment Battle – And What Comes Next

Despite significant investments in decentralized trials, digital platforms, and AI-driven outreach, clinical trial recruitment remains a persistent challenge. Approximately 70% of clinical trial sites fail to meet their projected enrollment targets, leading to delays and increased costs. For Contract...